Updates are available Correction dated 2022-06-07
Click to view Correction: https://doi.org/10.1186/s12943-022-01584-y
Updates are available Correction dated 2019-10-29
Click to view Correction: https://doi.org/10.1186/s12943-019-1083-2
-
Authors
Xia, Xin
Li, Xixi
Li, Fanying
Wu, Xujia
Zhang, Maolei
Zhou, Huangkai
Huang, Nunu
Yang, Xuesong
Xiao, Feizhe
Liu, Dawei
Yang, Lixuan
Zhang, Nu http://orcid.org/0000-0002-6783-3811
-
Funding
Funding for this research was provided by:
National Natural ScienceOutstanding Youth Foundation of China (81822033)
National Key Research and Development Program of China (2016YFA0503000)
- License Information
-
More Information
Article History
Received: 3 May 2019
Accepted: 14 August 2019
First Online: 30 August 2019
Change Date: 29 October 2019
Change Type: Correction
Change Details: In the published article [1], an error was noticed in Fig. 6B. The western blot results were reversed between the overexpression group and the knockdown group of circ-AKT3. The corrected and updated Fig. 6 is provided below. This error does not affect the findings or conclusions of the article.
Change Date: 7 June 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12943-022-01584-y
Ethics approval and consent to participate
: All patients consented to an institutional review board-approved protocol that allows comprehensive analysis of tumor samples (Ethics committee of Sun Yat-sen University). This study conforms to the Declaration of Helsinki.
: Written informed consent for publication was obtained from the patients. All authors have agreed to publish this manuscript.
: The authors declare that they have no competing interests.
